Report Detail
Global Chemotherapy-Induced Neutropenia Treatment Market Insights, Forecast to 2025
- RnM3402523 |
- 09 May, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
The global Chemotherapy-Induced Neutropenia Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Chemotherapy-Induced Neutropenia Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Chemotherapy-Induced Neutropenia Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chemotherapy-Induced Neutropenia Treatment in these regions.
This research report categorizes the global Chemotherapy-Induced Neutropenia Treatment market by top players/brands, region, type and end user. This report also studies the global Chemotherapy-Induced Neutropenia Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen
Sanofi
Novartis AG
Baxter International
Teva Pharmaceuticals Industries
Apotex
Dr. Reddy’s Laboratory
Biogenomics Limited
Ligand Pharmaceuticals
Market size by Product
Antibiotic Therapy
Colony-Stimulating Factor Therapy
Granulocyte Transfusion
Splenectomy Procedure
Others
Market size by End User
Hospitals
Ambulatory Surgical Center
Diagnostic Centers
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Chemotherapy-Induced Neutropenia Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Chemotherapy-Induced Neutropenia Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Chemotherapy-Induced Neutropenia Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Chemotherapy-Induced Neutropenia Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Chemotherapy-Induced Neutropenia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Chemotherapy-Induced Neutropenia Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Chemotherapy-Induced Neutropenia Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Chemotherapy-Induced Neutropenia Treatment Market Size Growth Rate by Product
- 1.4.2 Antibiotic Therapy
- 1.4.3 Colony-Stimulating Factor Therapy
- 1.4.4 Granulocyte Transfusion
- 1.4.5 Splenectomy Procedure
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Chemotherapy-Induced Neutropenia Treatment Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Ambulatory Surgical Center
- 1.5.4 Diagnostic Centers
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Chemotherapy-Induced Neutropenia Treatment Market Size
- 2.1.1 Global Chemotherapy-Induced Neutropenia Treatment Revenue 2014-2025
- 2.1.2 Global Chemotherapy-Induced Neutropenia Treatment Sales 2014-2025
- 2.2 Chemotherapy-Induced Neutropenia Treatment Growth Rate by Regions
- 2.2.1 Global Chemotherapy-Induced Neutropenia Treatment Sales by Regions
- 2.2.2 Global Chemotherapy-Induced Neutropenia Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Chemotherapy-Induced Neutropenia Treatment Sales by Manufacturers
- 3.1.1 Chemotherapy-Induced Neutropenia Treatment Sales by Manufacturers
- 3.1.2 Chemotherapy-Induced Neutropenia Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Chemotherapy-Induced Neutropenia Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Chemotherapy-Induced Neutropenia Treatment Revenue by Manufacturers
- 3.2.1 Chemotherapy-Induced Neutropenia Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Chemotherapy-Induced Neutropenia Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Chemotherapy-Induced Neutropenia Treatment Price by Manufacturers
- 3.4 Chemotherapy-Induced Neutropenia Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Chemotherapy-Induced Neutropenia Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Chemotherapy-Induced Neutropenia Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Chemotherapy-Induced Neutropenia Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Chemotherapy-Induced Neutropenia Treatment Sales by Product
- 4.2 Global Chemotherapy-Induced Neutropenia Treatment Revenue by Product
- 4.3 Chemotherapy-Induced Neutropenia Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Chemotherapy-Induced Neutropenia Treatment Breakdown Data by End User
6 North America
- 6.1 North America Chemotherapy-Induced Neutropenia Treatment by Countries
- 6.1.1 North America Chemotherapy-Induced Neutropenia Treatment Sales by Countries
- 6.1.2 North America Chemotherapy-Induced Neutropenia Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Chemotherapy-Induced Neutropenia Treatment by Product
- 6.3 North America Chemotherapy-Induced Neutropenia Treatment by End User
7 Europe
- 7.1 Europe Chemotherapy-Induced Neutropenia Treatment by Countries
- 7.1.1 Europe Chemotherapy-Induced Neutropenia Treatment Sales by Countries
- 7.1.2 Europe Chemotherapy-Induced Neutropenia Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Chemotherapy-Induced Neutropenia Treatment by Product
- 7.3 Europe Chemotherapy-Induced Neutropenia Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Chemotherapy-Induced Neutropenia Treatment by Countries
- 8.1.1 Asia Pacific Chemotherapy-Induced Neutropenia Treatment Sales by Countries
- 8.1.2 Asia Pacific Chemotherapy-Induced Neutropenia Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Chemotherapy-Induced Neutropenia Treatment by Product
- 8.3 Asia Pacific Chemotherapy-Induced Neutropenia Treatment by End User
9 Central & South America
- 9.1 Central & South America Chemotherapy-Induced Neutropenia Treatment by Countries
- 9.1.1 Central & South America Chemotherapy-Induced Neutropenia Treatment Sales by Countries
- 9.1.2 Central & South America Chemotherapy-Induced Neutropenia Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Chemotherapy-Induced Neutropenia Treatment by Product
- 9.3 Central & South America Chemotherapy-Induced Neutropenia Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Chemotherapy-Induced Neutropenia Treatment by Countries
- 10.1.1 Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Sales by Countries
- 10.1.2 Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Chemotherapy-Induced Neutropenia Treatment by Product
- 10.3 Middle East and Africa Chemotherapy-Induced Neutropenia Treatment by End User
11 Company Profiles
- 11.1 Amgen
- 11.1.1 Amgen Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Amgen Chemotherapy-Induced Neutropenia Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Amgen Chemotherapy-Induced Neutropenia Treatment Products Offered
- 11.1.5 Amgen Recent Development
- 11.2 Sanofi
- 11.2.1 Sanofi Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sanofi Chemotherapy-Induced Neutropenia Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sanofi Chemotherapy-Induced Neutropenia Treatment Products Offered
- 11.2.5 Sanofi Recent Development
- 11.3 Novartis AG
- 11.3.1 Novartis AG Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Novartis AG Chemotherapy-Induced Neutropenia Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Novartis AG Chemotherapy-Induced Neutropenia Treatment Products Offered
- 11.3.5 Novartis AG Recent Development
- 11.4 Baxter International
- 11.4.1 Baxter International Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Baxter International Chemotherapy-Induced Neutropenia Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Baxter International Chemotherapy-Induced Neutropenia Treatment Products Offered
- 11.4.5 Baxter International Recent Development
- 11.5 Teva Pharmaceuticals Industries
- 11.5.1 Teva Pharmaceuticals Industries Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Teva Pharmaceuticals Industries Chemotherapy-Induced Neutropenia Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Teva Pharmaceuticals Industries Chemotherapy-Induced Neutropenia Treatment Products Offered
- 11.5.5 Teva Pharmaceuticals Industries Recent Development
- 11.6 Apotex
- 11.6.1 Apotex Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Apotex Chemotherapy-Induced Neutropenia Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Apotex Chemotherapy-Induced Neutropenia Treatment Products Offered
- 11.6.5 Apotex Recent Development
- 11.7 Dr. Reddy’s Laboratory
- 11.7.1 Dr. Reddy’s Laboratory Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Dr. Reddy’s Laboratory Chemotherapy-Induced Neutropenia Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Dr. Reddy’s Laboratory Chemotherapy-Induced Neutropenia Treatment Products Offered
- 11.7.5 Dr. Reddy’s Laboratory Recent Development
- 11.8 Biogenomics Limited
- 11.8.1 Biogenomics Limited Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Biogenomics Limited Chemotherapy-Induced Neutropenia Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Biogenomics Limited Chemotherapy-Induced Neutropenia Treatment Products Offered
- 11.8.5 Biogenomics Limited Recent Development
- 11.9 Ligand Pharmaceuticals
- 11.9.1 Ligand Pharmaceuticals Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Ligand Pharmaceuticals Chemotherapy-Induced Neutropenia Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Ligand Pharmaceuticals Chemotherapy-Induced Neutropenia Treatment Products Offered
- 11.9.5 Ligand Pharmaceuticals Recent Development
12 Future Forecast
- 12.1 Chemotherapy-Induced Neutropenia Treatment Market Forecast by Regions
- 12.1.1 Global Chemotherapy-Induced Neutropenia Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Chemotherapy-Induced Neutropenia Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Chemotherapy-Induced Neutropenia Treatment Market Forecast by Product
- 12.2.1 Global Chemotherapy-Induced Neutropenia Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Chemotherapy-Induced Neutropenia Treatment Revenue Forecast by Product 2019-2025
- 12.3 Chemotherapy-Induced Neutropenia Treatment Market Forecast by End User
- 12.4 North America Chemotherapy-Induced Neutropenia Treatment Forecast
- 12.5 Europe Chemotherapy-Induced Neutropenia Treatment Forecast
- 12.6 Asia Pacific Chemotherapy-Induced Neutropenia Treatment Forecast
- 12.7 Central & South America Chemotherapy-Induced Neutropenia Treatment Forecast
- 12.8 Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Chemotherapy-Induced Neutropenia Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Chemotherapy-Induced Neutropenia Treatment . Industry analysis & Market Report on Chemotherapy-Induced Neutropenia Treatment is a syndicated market report, published as Global Chemotherapy-Induced Neutropenia Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Chemotherapy-Induced Neutropenia Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
